Human vaccine research in the European Union

Vaccine

Volumn 27, Issue 5, 2009, Pages 640-645

  Olesen, Ole F ^a   Lonnroth, Anna ^a   Mulligan, Bernard ^a  

^a EUROPEAN COMMISSION   (Belgium)

Author keywords

European Commission; FP6 research funding; Vaccines

Indexed keywords

ALZHEIMER DISEASE VACCINE; BCG VACCINE; HEPATITIS C VACCINE; HUMAN IMMUNODEFICIENCY VIRUS VACCINE; INFLUENZA VACCINE; MALARIA VACCINE; SEVERE ACUTE RESPIRATORY SYNDROME VACCINE; VACCINE;

DRUG RESEARCH; EPIDEMIC; EUROPEAN UNION; FUNDING; HUMAN; INFECTION CONTROL; PRIORITY JOURNAL; RESEARCH PRIORITY; REVIEW; VACCINE PRODUCTION;

BIOMEDICAL RESEARCH; COMMUNICABLE DISEASE CONTROL; EUROPEAN UNION; HUMANS; VACCINES;

EID: 58149479323     PISSN: 0264410X     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.vaccine.2008.11.064     Document Type: Review

References (8)

1. Mora M., Donati C., Medini D., Covacci A., and Rappuoli R. Microbial genomes and vaccine design: refinements to the classical reverse vaccinology approach. Curr Opin Microbiol 5 (2006) 532-536
2. Plotkin S.A. Vaccines: correlates of vaccine-induced immunity. Clin Infect Dis 47 (2008) 401-409
3. Demuth A., Aharonowitz Y., Bachmann T.T., Blum-Oehler G., Buchrieser C., Covacci A., et al. Pathogenomics: an updated European Research Agenda. Infect Genet Evol 8 3 (2008) 386-393
4. Schuchat A., and Bell B.P. Monitoring the impact of vaccines postlicensure: new challenges, new opportunities. Expert Rev Vaccines 7 4 (2008) 437-456
5. Rappuoli R., Miller H.I., and Falkow S. The intangible value of vaccination. Science 297 (2002) 937-939
6. Galambos L. What are the prospects for a new golden era in vaccines?. Eurohealth 14 (2008) 12-14
7. COM(2005) 179 of 27.04.2005. From the commission to the council and the European parliament: a European programme for action to confront HIV/AIDS, malaria and tuberculosis through external action; 2007-2011.
8. Shaw K. The 2003 SARS outbreak and its impact on infection control practices. Public Health 120 1 (2006) 8-14